BeStock  
Stocks › Medical Devices › GKOS

Glaukos GKOS

US equityMarket cap rank #1152Medical Devices
$237.31 −$0.79 (-0.33%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $237.31 0.00%
Open$238.87
Prev close$238.10
Day range$233.40 – $244.55
Volume1.09M
Market cap$14.05B
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±9.9%last 16 reports
Closed higher8 of 1650% of the time
Best reaction+33.6%
Worst reaction-20.0%

Stock move on the day after each report

-1.4%2023/Q4+6.2%2024/Q1+0.4%2024/Q2-2.7%2024/Q3-20.0%2024/Q4-11.4%2025/Q1-8.5%2025/Q2+13.9%2025/Q3+13.5%2025/Q4+22.8%2026/Q1+4.2%2026/Q2+33.6%2026/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q328 Oct 2026After Market±16.2%+33.65%Bigger than priced
2026/Q229 Jul 2026After Market±16.4%+4.24%Within range
2026/Q129 Apr 2026After Market±10.8%+22.84%Bigger than priced
2025/Q417 Feb 2026After Market±8.2%+13.47%Bigger than priced
2025/Q329 Oct 2025After Market±13.2%+13.89%Bigger than priced
2025/Q230 Jul 2025After Market±17.5%-8.46%Within range
2025/Q130 Apr 2025After Market±15.7%-11.36%Within range
2024/Q420 Feb 2025After Market±13.2%-20.01%Bigger than priced
2024/Q34 Nov 2024After Market±18.8%-2.68%Within range
2024/Q231 Jul 2024After Market±15.3%+0.38%Within range
2024/Q11 May 2024After Market±11.1%+6.19%Within range
2023/Q421 Feb 2024After Market±16.2%-1.43%Within range
2023/Q31 Nov 2023After Market±11.7%-7.58%Within range
2023/Q22 Aug 2023After Market±10.5%-0.39%Within range
2023/Q13 May 2023After Market±9.6%+8.85%Within range
2022/Q422 Feb 2023After Market±11.3%-3.13%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Glaucoma$151.99M 72.0%
  • Corneal Health$59.04M 28.0%

Latest reported quarter: Q3, ended Sep 2026

Revenue$211.03M+58.0% YoY
Operating profit$828,000.00+105.1% YoY
Net profit$2.02M+112.4% YoY
Diluted EPS$0.03+110.7% YoY
Free cash flow$36.49M+411.2% YoY
Operating cash flow$38.57M

Revenue, last 8 quarters

$105.5MDec '24$106.7MMar '25$124.1MJun '25$133.5MSep '25$143.1MDec '25$150.6MMar '26$185.6MJun '26$211.0MSep '26

Net profit, last 8 quarters

$-33.6MDec '24$-18.1MMar '25$-19.7MJun '25$-16.2MSep '25$-133.7MDec '25$-19.8MMar '26$-18.4MJun '26$2.0MSep '26

Profitability & balance sheet

Gross margin64.8%
Operating margin-25.3%
Net margin-24.6%
Return on equity-22.8%
Return on assets-17.2%
Return on invested capital-20.6%
Current ratio4.57
Liabilities / assets26.8%
Cash & investments$336.70M
Total debt$101.98M
Net cash (debt)$234.72M
Free cash flow / sales2.8%

Discussion

No comments yet — be the first to weigh in on GKOS.

Sign in to join the discussion.

Scroll to Top